{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:37:08Z","timestamp":1773041828263,"version":"3.50.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Incubation Program Project of Bethune International Peace Hospital","award":["2024FYQNXM02"],"award-info":[{"award-number":["2024FYQNXM02"]}]},{"DOI":"10.13039\/501100003787","name":"Hebei Natural Science Foundation","doi-asserted-by":"crossref","award":["H2024505013"],"award-info":[{"award-number":["H2024505013"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:p>We present a rare case of paraneoplastic neuromyelitis optica spectrum disorder (NMOSD) in a 50-year-old woman with a history of B3 thymoma, marked by dual positivity for AQP4-IgG and CV2\/CRMP5 antibodies. The patient developed sequential bilateral optic neuritis, with orbital MRI revealing enhancement of the left optic nerve. Serological analysis showed a high AQP4-IgG titer (1:320) and positive CV2\/CRMP5 antibodies, while other paraneoplastic markers were absent. Treatment with glucocorticoids and mycophenolate mofetil led to substantial visual recovery. This case underscores the association between thymoma and paraneoplastic NMOSD and suggests a potential interaction between AQP4- and CRMP5-related autoimmune responses. Although CV2\/CRMP5 antibodies are typically linked to lung cancer and thymoma, their coexistence with AQP4-IgG in NMOSD points to a distinct paraneoplastic mechanism. These findings support the need for thorough tumor screening in NMOSD patients with atypical features, particularly those with CV2\/CRMP5 seropositivity.<\/jats:p>","DOI":"10.3389\/fnins.2026.1747586","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:46:55Z","timestamp":1773038815000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Paraneoplastic neuromyelitis optica spectrum disorder with dual AQP4-IgG and CRMP5 antibodies following thymectomy: a case report"],"prefix":"10.3389","volume":"20","author":[{"given":"Yucai","family":"Chuai","sequence":"first","affiliation":[{"name":"Department of Special Medical Services, Bethune International Peace Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bethune International Peace Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bethune International Peace Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Bethune International Peace Hospital","place":["Shijiazhuang, Hebei, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.msard.2017.12.012","article-title":"Paraneoplastic neuromyelitis optica spectrum disorder: a single center cohort description with two cases of histological validation","volume":"20","author":"Beauchemin","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3109\/00207454.2015.1054481","article-title":"Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature","volume":"126","author":"Cai","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jneuroim.2010.07.016","article-title":"Aquaporin-4 water channel expression by thymoma of patients with and without myasthenia gravis","volume":"227","author":"Chan","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2282","DOI":"10.1002\/brb3.2282","article-title":"AQP4-IgG positive paraneoplastic NMOSD: a case report and review","volume":"11","author":"Ding","year":"2021","journal-title":"Brain Behav."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/WCO.0b013e328359da15","article-title":"Paraneoplastic neurological syndromes","volume":"25","author":"Graus","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","article-title":"Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes","volume":"61","author":"Honnorat","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin. Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1424243","DOI":"10.3389\/fimmu.2024.1424243","article-title":"Paraneoplastic neuromyelitis optica spectrum disorder associated with ovarian dysgerminoma: a case report and literature review","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00262-007-0369-1","article-title":"CRMP5 antibodies in patients with small-cell lung cancer or thymoma","volume":"57","author":"Monstad","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/archneur.65.5.629","article-title":"Aquaporin-4 autoantibodies in a paraneoplastic context","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1177\/1352458517731914","article-title":"Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Mult. Scler."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1007\/s10072-021-05055-y","article-title":"Paraneoplastic neuromyelitis optica spectrum disorders: a case series","volume":"42","author":"Virgilio","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann. Neurol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1747586\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:46:56Z","timestamp":1773038816000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2026.1747586\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":15,"alternative-id":["10.3389\/fnins.2026.1747586"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2026.1747586","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"article-number":"1747586"}}